Skip to main content
. 2012 Jul 17;107(4):652–657. doi: 10.1038/bjc.2012.321

Figure 1.

Figure 1

Cell growth inhibitory effects of DHMEQ in LNCaP and PC-3 prostate cancer cells. Cells were treated with various concentrations of 24-h exposure of DHMEQ. *Significantly different from the vehicle control, P<0.05.